p53 is a tumor suppressor protein that functions as a cellular genome guardian. Under normal growth conditions, p53 is kept at low levels due to a fast protein turnover rate. When cells are stressed, p53 becomes stabilized and leads to cell cycle arrest. This transient block allows cells to overcome the stress and efficiently repair DMA lesions, if necessary. When the damage is too severe to be restored, p53 induces apoptosis. The dual function of p53 lies in its ability to act as a sequence-specific transcription factor that activates transcription of gene products involved in cell cycle control and apoptosis. Not surprisingly, p53 is a frequent target for DNA tumor virus-encoded oncoproteins that are able to functionally inactivate p53 and block the activation of p53 target gene transcription. For over a decade, this inhibition of p53 transactivation has been attributed to the effect of these viral oncoproteins on p53 protein stability. Recently, we have uncovered a new pathway for human papillomavirus (HPV)-encoded E6 oncoprotein to inactivate the function of chromatin-bound p53 by inhibiting acetylation of p53 and nucleosomal core histones on the p53-targeted human p21 gene. To understand the repression mechanisms employed by HPV E6 and other DNA tumor virus-encoded oncoproteins, we propose two aims. 1) To identify cellular proteins involved in E6-mediated repression of p53 target gene transcription. We found that both p53 and histone acetyltransferase (HAT) p300 are essential for E6-mediated repression of p21 gene transcription. Since p300 autoacetylation is not inhibited by E6, we hypothesize that acetylated p300 may provide a protein code for recruitment of other cellular proteins to further modify the function of p300 and p53, resulting in a condensed chromatin structure on p53 target genes. This hypothesis will be tested by performing in vitro chromatin transcription, HAT assays, DNA/chromatin-binding assays as well as in vivo ChIP, RT-PCR, siRNA and reporter gene assays to follow the recruitment of transcription factors and cofactors to p53-regulated genes. Moreover, we will identify additional cellular proteins involved in this repression pathway by isolating and characterizing E6 cellular complexes. An unbiased biochemical fractionation will also be conducted to identify cellular factors involved in E6 repressor function. 2) To define the repression mechanism used bv other DNA tumor virus-encoded oncoproteins. We will examine whether SV40 and polyomavirus large T-antigens and adenovirus E1B-55K and E1B-19K proteins also employ a similar but non-identical mechanism to repress p53 target gene transcription. Collectively, these studies will establish a general principle of this novel repression mechanism employed by DNA tumor virus- encoded oncoproteins, independently of the proteasome-mediated degradation pathway, and provide a new direction for the development of drug inhibitors to block the propagation of these human pathogens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA124760-05S1
Application #
8514765
Study Section
Molecular Genetics A Study Section (MGA)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
2007-09-13
Project End
2013-07-31
Budget Start
2011-08-01
Budget End
2013-07-31
Support Year
5
Fiscal Year
2012
Total Cost
$75,000
Indirect Cost
$27,819
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Wu, Shwu-Yuan; Lee, A-Young; Lai, Hsien-Tsung et al. (2013) Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell 49:843-57
Lai, Hsien-Tsung; Chiang, Cheng-Ming (2013) Bimolecular Fluorescence Complementation (BiFC) Assay for Direct Visualization of Protein-Protein Interaction in vivo. Bio Protoc 3:
Quinlan, Edward J; Culleton, Sara P; Wu, Shwu-Yuan et al. (2013) Acetylation of conserved lysines in bovine papillomavirus E2 by p300. J Virol 87:1497-507
Chiang, Cheng-Ming (2012) p53-Aurora A mitotic feedback loop regulates cell cycle progression and genomic stability. Cell Cycle 11:3719-20
Rabellino, Andrea; Carter, Brandon; Konstantinidou, Georgia et al. (2012) The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA. Cancer Res 72:2275-84
Hsu, C-H; Peng, K-L; Jhang, H-C et al. (2012) The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription. Oncogene 31:2335-49
Loewenstein, Paul M; Wu, Shwu-Yuan; Chiang, Cheng-Ming et al. (2012) The adenovirus E1A N-terminal repression domain represses transcription from a chromatin template in vitro. Virology 428:70-5
Cai, Di; Lee, A-Young; Chiang, Cheng-Ming et al. (2011) Peptoid ligands that bind selectively to phosphoproteins. Bioorg Med Chem Lett 21:4960-4
Wang, Wei-Ming; Wu, Shwu-Yuan; Lee, A-Young et al. (2011) Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription. J Biol Chem 286:40974-86
Huang, Charlie C; Li, Yi; Lopez, Alex B et al. (2010) Temporal regulation of Cat-1 (cationic amino acid transporter-1) gene transcription during endoplasmic reticulum stress. Biochem J 429:215-24

Showing the most recent 10 out of 23 publications